Latest news
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad - BioSpaceBioSpace · Wed, 05 Aug 2026 13:39:37 GMTRumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms - BioSpaceBioSpace · Wed, 05 Aug 2026 11:21:15 GMTRecon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPSRAPS · Mon, 03 Aug 2026 16:51:00 GMTCapricor CEO won’t rule out legal action against FDA after negative adcomm - BioSpaceBioSpace · Fri, 31 Jul 2026 18:43:14 GMTFDA advisers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting - BioSpaceBioSpace · Wed, 29 Jul 2026 07:00:00 GMTCapricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more - BioSpaceBioSpace · Wed, 29 Jul 2026 07:00:00 GMTUPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMTFDA has recommitted to adcomms—but to what end? - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMT